Dr. Wright, in fact, comes into the narrative in 1938 via a severe attack of thrombophlebitis which he suffered after an operation. A little later, he was responsible for using heparin in the treatment of acute migrating thrombophlebitis and a few years later (1942) he published one of the early reports on the use of Dicumarol in human beings. In the same year he and his colleagues began to treat patients suffering from myocardial infarction with Dicumarol.
SYMPOSIUM-ANTICOAGULANTS AND CORONARY DISEASE
in 1946 and, in the same year, the famous cooperative study, with Dr. Wright as chairman, was authorized by the American Heart Association. Dr. Wright and colleagues published a progress report in 1948 and a full report 6 years later. Their conclusion, that '"anticoagulant therapy should be used in all cases of coronary thrombosis with myocardial infarction unless a definite contraindication exists," is widely accepted in this country and in some foreign ones. The conclusion has never been uncontested but the frequency of serious attacks on it has seemed to decrease in recent years. Recommendations that anticoagulants be used indefinitely to prevent myocardial infarction, or in the treatment of angina pectoris, have never been as widely accepted as the admonition that all patients with myocardial infarction should be so treated. But 
